分析MDS炎症指标与临床特征之间的相关性:全面分析
ZhongLi Hu1,2, Lijia Pei3, ZhongTing Hu4
1Department of Haematology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Mediators of inflammation
|June 27, 2025
概括
这项研究发现,像中性粒细胞与淋巴细胞的比率 (NLR) 和血小板与淋巴细胞的比率 (PLR) 这样的炎症标志物与肌肉发育综合征 (MDS) 的临床特征相关. 这些标志物有助于MDS诊断和治疗策略,反映疾病负担和进展.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓发育综合征 (MDS) 是一组克隆性造血干细胞疾病.
- 炎症在MDS的发病和进展中起着至关重要的作用.
- 中性粒细胞与淋巴细胞的比率 (NLR),单细胞与淋巴细胞的比率 (MLR) 和血小板与淋巴细胞的比率 (PLR) 是新兴的炎症标志物.
研究的目的:
- 调查NLR,MLR和PLR与新诊断的MDS患者临床特征之间的相关性.
- 探索这些炎症标志物在MDS中的诊断和预后价值.
- 为早期评估治疗疗效和个性化治疗策略提供基础.
主要方法:
- 对70名MDS患者的骨髓涂抹和流动细胞计免疫型的分析.
- 对临床特征和炎症标志物之间的多参数线性相关性进行比较分析.
- 基于MDS亚型,免疫类型特征和形态特征的差异性相关性分析.
主要成果:
- 在NLR和PLR中,MDS的诊断特异性很好 (AUC=0.9169,0.8312).
- MLR与白细胞计数相关 (r=0.661,p=0.0004),NLR与LDH相关 (r=0.313,p=0.037).
- 在不同的MDS世卫组织分类和免疫类型组中观察到炎症标志物的显著差异. CD34比例与NLR负相关 (r=-0.296,p=0.0129),较低的PLR预测更长的生存时间.
结论:
- 炎症标志物 (NLR,MLR,PLR) 与MDS的临床特征和瘤负担有显著的相关性.
- 这些标记提供了辅助诊断证据,并反映了基于疾病状况的差异.
- 这些发现表明,这些标记物可以指导治疗策略,通过调节炎症趋势来抑制MDS进展到急性白血病.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Inflammatory Bowel Disease II: Crohn's Disease
399
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
399
Inflammatory Bowel Disease I: Ulcerative Colitis
342
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
342


